Patrick James Orme

Array ( [id] => 6725492 [patent_doc_number] => 20030207804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Modified peptide nucleic acids' [patent_app_type] => new [patent_app_number] => 10/155920 [patent_app_country] => US [patent_app_date] => 2002-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 23668 [patent_no_of_claims] => 124 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207804.pdf [firstpage_image] =>[orig_patent_app_number] => 10155920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756347 [patent_doc_number] => 20030004124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'BTF3: an inhibitor of apoptosis' [patent_app_type] => new [patent_app_number] => 10/153344 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 26020 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004124.pdf [firstpage_image] =>[orig_patent_app_number] => 10153344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252564 [patent_doc_number] => 20050074878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Antisense modulation of ptpn2 expression' [patent_app_type] => utility [patent_app_number] => 10/475146 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25111 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074878.pdf [firstpage_image] =>[orig_patent_app_number] => 10475146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769870 [patent_doc_number] => 20030215810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Simple catalytic DNA biosensors for ions based on color changes' [patent_app_type] => new [patent_app_number] => 10/144679 [patent_app_country] => US [patent_app_date] => 2002-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14813 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215810.pdf [firstpage_image] =>[orig_patent_app_number] => 10144679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110436 [patent_doc_number] => 20020172680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Diagnosis of metastatic cancer by the mts-1 gene' [patent_app_type] => new [patent_app_number] => 10/135152 [patent_app_country] => US [patent_app_date] => 2002-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 26848 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172680.pdf [firstpage_image] =>[orig_patent_app_number] => 10135152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761918 [patent_doc_number] => 20030125280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Tissue specific and target RNA-specific ribozymes as antimicrobial therapeutics against microbial pathogens' [patent_app_type] => new [patent_app_number] => 10/127025 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11122 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125280.pdf [firstpage_image] =>[orig_patent_app_number] => 10127025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865100 [patent_doc_number] => 20030190626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Phosphorothioate monoester modified oligomers' [patent_app_type] => new [patent_app_number] => 10/119432 [patent_app_country] => US [patent_app_date] => 2002-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18815 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190626.pdf [firstpage_image] =>[orig_patent_app_number] => 10119432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761146 [patent_doc_number] => 20030124507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Method of generating conditionally expressed mutant cells using expressible antisense sequences' [patent_app_type] => new [patent_app_number] => 10/099198 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10965 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124507.pdf [firstpage_image] =>[orig_patent_app_number] => 10099198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519260 [patent_doc_number] => 20020192217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Methods for regulation of immune responses to conditions involving mediator-induced pathology' [patent_app_type] => new [patent_app_number] => 10/094732 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26832 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192217.pdf [firstpage_image] =>[orig_patent_app_number] => 10094732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750970 [patent_doc_number] => 20030045491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'TTK in diagnosis and as a therapeutic target in cancer' [patent_app_type] => new [patent_app_number] => 10/081119 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20124 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045491.pdf [firstpage_image] =>[orig_patent_app_number] => 10081119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706320 [patent_doc_number] => 20030153054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Methods and compositions for use in spliceosome mediated RNA trans-splicing' [patent_app_type] => new [patent_app_number] => 10/075028 [patent_app_country] => US [patent_app_date] => 2002-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11496 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20030153054.pdf [firstpage_image] =>[orig_patent_app_number] => 10075028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7254900 [patent_doc_number] => 20050075299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Antisense modulation of wrn espression' [patent_app_type] => utility [patent_app_number] => 10/467182 [patent_app_country] => US [patent_app_date] => 2002-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25196 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075299.pdf [firstpage_image] =>[orig_patent_app_number] => 10467182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7251893 [patent_doc_number] => 20050074762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Adiponectin-associated protein' [patent_app_type] => utility [patent_app_number] => 10/467102 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13381 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074762.pdf [firstpage_image] =>[orig_patent_app_number] => 10467102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6814104 [patent_doc_number] => 20030073654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Stabilized transient gene expression' [patent_app_type] => new [patent_app_number] => 10/047649 [patent_app_country] => US [patent_app_date] => 2002-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24541 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073654.pdf [firstpage_image] =>[orig_patent_app_number] => 10047649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921038 [patent_doc_number] => 20020114784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA' [patent_app_type] => new [patent_app_number] => 10/038984 [patent_app_country] => US [patent_app_date] => 2002-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12848 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20020114784.pdf [firstpage_image] =>[orig_patent_app_number] => 10038984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6468722 [patent_doc_number] => 20020151063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Methods for modulating apoptotic cell death' [patent_app_type] => new [patent_app_number] => 10/028415 [patent_app_country] => US [patent_app_date] => 2001-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14604 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151063.pdf [firstpage_image] =>[orig_patent_app_number] => 10028415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797032 [patent_doc_number] => 20030175906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Nuclease resistant chimeric oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/013295 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 34767 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175906.pdf [firstpage_image] =>[orig_patent_app_number] => 10013295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 923173 [patent_doc_number] => 07319145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Methylenetetrahydrofolate reductase inhibitors and use thereof' [patent_app_type] => utility [patent_app_number] => 10/433392 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15608 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319145.pdf [firstpage_image] =>[orig_patent_app_number] => 10433392 [rel_patent_id] =>[rel_patent_doc_number] =>)